American Journal of Kidney Diseases
Volume 53, Issue 5 , Pages 804-814, May 2009

Conversion of Vascular Access Type Among Incident Hemodialysis Patients: Description and Association With Mortality

  • Brian D. Bradbury, DSc, MA

      Affiliations

    • Department of Biostatistics and Epidemiology, Amgen Inc, Thousand Oaks, CA
    • Corresponding Author InformationAddress correspondence to Brian D. Bradbury, DSc, MA, 1 Amgen Center Dr, MS: 24-2-A, Thousand Oaks, CA 91320
  • ,
  • Fangfei Chen, MPH

      Affiliations

    • Department of Biostatistics and Epidemiology, Amgen Inc, Thousand Oaks, CA
  • ,
  • Anna Furniss, MS

      Affiliations

    • Colorado Health Institute, Denver, CO
  • ,
  • Ronald L. Pisoni, PhD, MS

      Affiliations

    • Arbor Research Collaborative for Health, Ann Arbor, MI
  • ,
  • Marcia Keen, PhD

      Affiliations

    • Medical Research Management, Amgen Inc, Thousand Oaks, CA
  • ,
  • Donna Mapes, PhD

      Affiliations

    • Arbor Research Collaborative for Health, Ann Arbor, MI
  • ,
  • Mahesh Krishnan, MD, MPH

      Affiliations

    • Medical Research Management, Amgen Inc, Thousand Oaks, CA

Received 13 May 2008; accepted 20 November 2008. published online 06 March 2009.

Background

Limited data exist describing vascular access conversions during the first year on dialysis therapy or the effect of converting to and from a catheter on subsequent mortality risk.

Study Design

Retrospective cohort study.

Setting & Participants

We studied a random sample of incident US hemodialysis patients (initiated long-term dialysis < 30 days before study entry) in the Dialysis Outcomes and Practice Patterns Study (DOPPS; 1996-2004).

Predictors

At dialysis therapy initiation, we assessed vascular access type in use (arteriovenous fistula [AVF], arteriovenous graft [AVG], or catheter) and other patient characteristics. We characterized changes in vascular access type (conversions) by using regularly collected functional status information.

Outcome & Measurements

We assessed time to all-cause mortality. We first described conversions, then used time-dependent Cox regression to estimate mortality hazard ratios (HRs) for conversions from a catheter to a permanent vascular access (versus no conversion) and conversions from a permanent vascular access to a catheter (versus no conversion).

Results

The study included 4,532 patients; 69.2% were dialyzing with a catheter; 17.6%, with an AVG; and 13.1%, with an AVF. In patients initiating therapy with an AVF or AVG, 22% experienced a conversion (failure), and median times to first failure were 62 and 84 days, respectively. In catheter patients, 59% converted to an AVF/AVG (predominantly AVG [57%]); median times to first conversion were 92 and 66 days, respectively. Conversion to a permanent access was associated with an adjusted mortality HR of 0.69 (95% confidence interval, 0.55 to 0.85). The effect was similar for conversion to an AVF or AVG, and these persisted across demographic groups and facilities with different conversion practices. Conversion from a permanent vascular access to a catheter was associated with an adjusted mortality HR of 1.81 (95% confidence interval, 1.22 to 2.68).

Limitations

Potential for residual confounding because of unmeasured factors influencing decision to convert.

Conclusion

Vascular access conversions are common in incident patients. Continued efforts to increase early nephrologist referral and permanent vascular access placement may help decrease mortality risk in incident dialysis patients.

Index Words: Vascular access, hemodialysis, mortality

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Originally published online as doi:10.1053/j.ajkd.2008.11.031 on March 6, 2009.

PII: S0272-6386(09)00031-6

doi:10.1053/j.ajkd.2008.11.031

American Journal of Kidney Diseases
Volume 53, Issue 5 , Pages 804-814, May 2009